Biocon Biologics' facility has received a certificate of GMP compliance for Bevacizumab from the representative European inspection authority -- Health Products Regulatory Authority (HPRA), Ireland.
Biocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about USD 4.9 billion. Serum Institute Life Sciences (SILS) is a subsidiary of Serum Institute of India (SII).
Executive Chairperson, Biocon Kiran Mazumdar Shaw spoke at the India TV Conclave. She talked about the hurdles in ramping up vaccination. Apart from this, she said, "People who haven't ever tested positive for COVID 19 should be prioritized for vaccination, as they're more susceptible to it".
Executive Chairperson Kiran Mazumdar-Shaw said the consolidated revenue for Q3 FY21 was driven by 13 per cent growth in research services and 11 per cent in biosimilar business segments.
The executive chairperson of Biocon, Kiran Mazumdar Shaw said, "It is an injection containing 25mg/5mL solution for emergency use in India for the treatment of Cytokine Release distress syndrome (ADRS) patients caused by the COVID-19".
Kiran Mazumdar Shaw, the Executive Chairperson of Biocon Limited, announced Monday that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19.
Biotechnology major Biocon on Saturday announced that its "breakthrough drug," Itolizumab has received Drugs Controller General of India's (DCGI) approval for its use in moderate to severe COVID-19 patients.
The US Food and Drug Administration (USFDA) has accepted biologics license application by Mylan and Biocon for proposed biosimilar to Bevacizumab for review, according to a regulatory filing.
Biotechnology major Biocon would make three generic drugs for hard-selling in China through partnership, the company said on Saturday.
Biotechnology pioneer Kiran Mazumdar-Shaw says the latest list of 100 rich persons in India reflects the state of the economy.
Shah Rukh reveals where he draws his inspiration for success from. The Bollywood superstar considers Kiran Mazumdar Shaw, the chairperson of leading Indian biotech company, Biocon, his role model.
New Delhi: Biotech firm Biocon reported a 13 percent dip in net profit for October-December quarter at Rs 91 crore and said it will sell 10-15 percent stake in its research services arm Syngene.The company
Hyderabad: Pharmaceutical giant Biocon is contemplating setting up a manufacturing facility in Visakhapatnam, Andhra Pradesh government said Sunday."Biocon Chairperson and Managing Director (CMD) Kiran Mazumdar Shaw met Chief Minister N Chandrababu Naidu at his residence
New Delhi: Biotechnology major Biocon today reported a flat growth in its consolidated net profit at Rs 102.05 crore for the quarter ended September 30, 2014.The company had posted a net profit after tax and
Bangalore: India's biotechnology queen and Biocon chairperson Kiran Mazumdar-Shaw has been awarded the coveted Global Economy Prize for business by the Kiel Institute in Germany during its centenary celebrations."Mazumdar-Shaw is the first Indian woman and
New Delhi: Biotechnology major Biocon today reported a 54.51% decline in its consolidated net profit at Rs 113.08 crore for the fourth quarter ended March 31, 2014. The company had posted a net profit of
New Delhi, July 26: Biocon has reported a 18.65 per cent rise in consolidated net profit at Rs 93.50 for the first quarter ended June 30, 2013 mainly on account of strong performance in the
Bangalore, April 28: India's biotechnology major Biocon Ltd posted consolidated net profit of Rs.509 crore for fiscal 2012-13, registering a whopping 51 percent year-on-year (YoY) growth over previous fiscal (2011-12) at Rs.338 crore.In a regulatory
New Delhi, Jan 25: Biotechnology major Biocon on Friday posted a 9.38% increase in its consolidated net profit at Rs. 92.81 crore for the third quarter ended December 31, 2012.The company had posted a net
Pune, Jan 24: Kiran Mazumdar-Shaw, CMD of Biocon, has been chosen to be on its board on trustees by The United States Pharmacopeial Convention (USP), a non-profit, standards setting organisation that advances public health through
Top News
Latest News
